April 10, 2026
1 min read

STAT+: GSK says goodbye to leucovorin (again)

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

Buyer beware: If you are an avid consumer of WAP Sensual Enhancement, the Food and Drug Administration says the pill “may be harmful.”

Want to learn about other dubious products under federal scrutiny? Scroll down.

Continue to STAT+ to read the full story…

Leave a Reply

Your email address will not be published.

Previous Story

Starting material sourcing bottlenecks increase US drug shortage risks: report

Next Story

Title X Funding Restored, but New Rules Raise Concerns MedNews

Previous Story

Starting material sourcing bottlenecks increase US drug shortage risks: report

Next Story

Title X Funding Restored, but New Rules Raise Concerns MedNews

Latest from Blog

Go toTop